Dealings in Listed Securities (Chapter 14 of Listing Requirements)
29/11/2021DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period
| SUNZEN BIOTECH BERHAD |
| Subject | Dealings Outside Closed Period |
| No | Salutation | Name | Designation | Description Of "Others" Designation |
MR |
Teo Yek Ming |
Others |
Group Managing Director cum Group Chief Executive Officer |
|
| Type of Transaction | Others | |||
| Description of "Others" Type of Transaction | Exercise of Options | |||
| Date of Transaction | 25 Nov 2021 | |||
| Description of Securities |
Ordinary Shares |
|||
| No of Securities Transacted | 14,330,000 | |||
| % of Securities Transacted | 2.310 | |||
| Consideration | Malaysian Ringgit (MYR) 0.139 | |||
| Remarks : |
Sunzen Biotech Berhad wishes to inform that the Company has received notification from Teo Yek Ming, the Managing Director/Group Chief Executive Officer in relation to change of his interest in securities of the Company arising from exercise of options under the Companys Share Issuance Scheme. |
Announcement Info
| Company Name | SUNZEN BIOTECH BERHAD |
| Stock Name | SUNZEN |
| Date Announced | 29 Nov 2021 |
| Category | Dealings in Listed Securities (Chapter 14 of Listing Requirements) |
| Reference Number | DLR-25112021-00007 |
Related Announcements for SUNZEN